» Articles » PMID: 17127260

Osteoclast Differentiation and Gene Regulation

Overview
Journal Front Biosci
Specialty Biology
Date 2006 Nov 28
PMID 17127260
Citations 56
Authors
Affiliations
Soon will be listed here.
Abstract

Osteoclasts, the bone resorbing cells, play a key role both in normal bone remodeling and in the skeletal osteopenia of arthritis, osteoporosis, periodontal disease and certain malignancies. Osteoclast cellular commitment, differentiation and function depend upon the establishment of specific patterns of gene expression achieved through networks of transcription factors activated by osteoclastogenic cytokines. This review is an updated look at the various transcription factors and cytokines that have been demonstrated to play critical roles in osteoclast differentiation and function, along with their known animal models, such as: PU.1, Mcsf, RANKL, NF-kappaB, AP-1, NFATc1, Mitf, Myc, and Src. Further studies on these transcription factors and cytokines will not only expand our basic understanding of the molecular mechanisms of osteoclast differentiation, but will also aid our ability to develop therapeutic means of intervention in osteoclast-related diseases.

Citing Articles

Neoandrographolide inhibits mature osteoclast differentiation to alleviate bone loss and treat osteoporosis.

Tang K, Deng W, Huang Z, Chen S, Zhu Z, Lin S Front Pharmacol. 2025; 16:1466057.

PMID: 40008134 PMC: 11851123. DOI: 10.3389/fphar.2025.1466057.


The effect of low-level laser therapy on osteoclast differentiation: Clinical implications for tooth movement and bone density.

Huang C, Le H, Tsai H, Tang C, Yu J J Dent Sci. 2024; 19(3):1452-1460.

PMID: 39035342 PMC: 11259655. DOI: 10.1016/j.jds.2024.03.023.


Cellular response of advanced triple cultures of human osteocytes, osteoblasts and osteoclasts to high sulfated hyaluronan (sHA3).

Wirsig K, Bacova J, Richter R, Hintze V, Bernhardt A Mater Today Bio. 2024; 25:101006.

PMID: 38445011 PMC: 10912908. DOI: 10.1016/j.mtbio.2024.101006.


Eosinophils preserve bone homeostasis by inhibiting excessive osteoclast formation and activity via eosinophil peroxidase.

Andreev D, Kachler K, Liu M, Chen Z, Krishnacoumar B, Ringer M Nat Commun. 2024; 15(1):1067.

PMID: 38316791 PMC: 10844633. DOI: 10.1038/s41467-024-45261-8.


Hydroxychavicol Inhibits In Vitro Osteoclastogenesis via the Suppression of NF-κB Signaling Pathway.

Srihirun S, Mathithiphark S, Phruksaniyom C, Kongphanich P, Inthanop W, Sriwantana T Biomol Ther (Seoul). 2024; 32(2):205-213.

PMID: 38298094 PMC: 10902706. DOI: 10.4062/biomolther.2023.067.